![A person stating at screens](https://www.amcp.org/sites/default/files/styles/card_fullsize/public/images/Person%20with%20Technology.jpg.webp?itok=BTrLT_Ei)
AMCP supports increased access to Prescription Digital Therapeutics (PDTs). PDTs are software-based therapies that deliver clinical benefits to patients, either alone or in combination with other forms of treatment. These therapeutics require a prescription and are subject to oversight by the Food and Drug Administration (FDA). To be approved by the FDA, PDTs must demonstrate both safety and efficacy.